Latest in Science

Image credit:

US government says Theranos lab jeopardizes patients' health

More bad news for the medical startup.
1 Shares
Share
Tweet
Share
Save

Sponsored Links

Federal regulators have sent a letter to troubled Theranos Labs and the news is not promising. The (CMS) Centers for Medicare and Medicaid Services states in a letter that it conducted a CLIA recertification survey of the lab and found it that it was not in compliance. In the letter signed by Karen Fuller, manager of state oversight for CMS, the agency noted that in regard to the hematology portion of the lab "it was determined that that the deficient practices of the laboratory pose immediate jeopardy to patient health and safety."

CMS says the company has 10 calendar days from date of receipt (January 25) to correct all the issues in question. If it doesn't, the lab may not be certified to perform tests under the CLIA program. Information about the letter leaked earlier this week.

The agency also highlighted issues with the analytic system and lab personnel performing high complexity testing.

That's bad news for the startup that's been criticized about its finger-prick testing technology. In October it was reported that the FDA only certified one out of the hundred or so tests the Theranos' technology was supposed to be able to get from a drop of blood. Plus, it was also reported that the company wasn't even using its proprietary technology to conduct most of those tests.

Concerning the letter from the CMS, Theranos sent Engadget an email with the following statement:

This survey of our Newark, CA lab began months ago and does not reflect the current state of the lab. As the survey took place we were simultaneously conducting a comprehensive review of our laboratory's systems, processes and procedures to ensure that we have best-in-class quality systems. We value engagement with our regulators, and are committed to ensuring that all our labs operate at the highest standards. We are still reviewing the report, but we addressed many of the observations during the survey and are actively continuing to take corrective action. A full plan of correction will be submitted to CMS within days.

It also pointed out that the notice is only about its Newark, California facility and does not affect its lab in Arizona.

All products recommended by Engadget are selected by our editorial team, independent of our parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission.
Comment
Comments
Share
1 Shares
Share
Tweet
Share
Save

Popular on Engadget

Two Halo characters are joining ‘Gears 5’

Two Halo characters are joining ‘Gears 5’

View
Sony Interactive snaps up 'Spider-Man' developer Insomniac Games

Sony Interactive snaps up 'Spider-Man' developer Insomniac Games

View
Microsoft’s SMS Organizer will declutter your texts

Microsoft’s SMS Organizer will declutter your texts

View
Twitter bans advertising from state-controlled news outlets

Twitter bans advertising from state-controlled news outlets

View
'Cyberpunk 2077' and 'Mortal Kombat 11' are coming to Google Stadia

'Cyberpunk 2077' and 'Mortal Kombat 11' are coming to Google Stadia

View

From around the web

Page 1Page 1ear iconeye iconFill 23text filevr